谷歌浏览器插件
订阅小程序
在清言上使用

A Protocol of a Single Arm, Prospective, Open-Label, Multicenter, Phase II Study of Ramucirumab and Erlotinib in Treatment-Naïve Non-Small Cell Lung Cancer Patients with EGFR Mutation and Brain Metastases (SPIRAL-BRAIN Study)

Translational Lung Cancer Research(2023)

引用 1|浏览1
关键词
Non-small cell lung cancer (NSCLC),epidermal growth factor receptor mutation (EGFR mutation),epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI),brain metastasis,vascular endothelial growth factor or vascular endothelial growth factor receptor inhibitor (VEGF or VEGFR inhibitor)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要